Share
Title
The time for long-acting is now – taking a new approach in treatment of people living with HIV
Code
SA48
Session Type
Sponsor satellite
Track
Not applicable
Channel
Channel 2
Date Time
20 July 19:00- 20:30
Local Date Time
19:00 - 20:30 W. Europe Daylight Time
Chair:
Matthew BOSSE, ViiV Healthcare, United States
Organizer:
ViiV Healthcare

Long-acting (LA) HIV medicines represent a new approach in HIV treatment by providing people living with HIV an alternative to daily dosing. In this symposium, people living with HIV will share their experience with treatment. An expert faculty will outline the clinical need and latest data, and will describe suitable patients for treatment and how to successfully incorporate the regimen into today’s clinical practice. (Intended for Healthcare Professionals only) SmPC Vocabria + Rekambys EU+DE SmPC Dovato EU+DE SmPC Rukobia EU+DE

5 min
 Chair's Welcome and Introduction
Matthew BOSSE, ViiV Healthcare, United States
10 min
 Patient Perspective: Understanding the Need for and Experience with Long-acting Treatment – Patient video
10 min
 Patient Perspective: Clinician Panel Reflection on the Patient Perspective
Matthew BOSSE, ViiV Healthcare, United States
Olaf DEGEN, University Hospital Hamburg-Eppendorf, Germany
Babafemi TAIWO, Feinberg School of Medicine, Northwestern University, United States
10 min
 Clinician Perspective: Bringing the Data to Life – Clinical Experience with Long-acting Treatment
Babafemi TAIWO, Feinberg School of Medicine, Northwestern University, United States
10 min
 Clinician Perspective: Getting Started – Identifying Appropriate Patients and Sharing Implementation Tips for Long-acting Treatment
Olaf DEGEN, University Hospital Hamburg-Eppendorf, Germany
15 min
 Clinician Perspective: Panel Discussion
Matthew BOSSE, ViiV Healthcare, United States
Olaf DEGEN, University Hospital Hamburg-Eppendorf, Germany
Babafemi TAIWO, Feinberg School of Medicine, Northwestern University, United States
25 min
 Live Q&A
Matthew BOSSE, ViiV Healthcare, United States
Olaf DEGEN, University Hospital Hamburg-Eppendorf, Germany
Babafemi TAIWO, Feinberg School of Medicine, Northwestern University, United States
5 min
 Summary and Close
Matthew BOSSE, ViiV Healthcare, United States